BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 417545)

  • 1. Different composition of the erythropoietic tissue in bone marrow, spleen and liver in myelofibrosis.
    Sjögren U
    Acta Haematol; 1978; 59(4):231-6. PubMed ID: 417545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different composition and mitotic activity of the haemopoietic tissue in bone marrow, spleen and liver in chronic myeloid leukaemia.
    Sjögren U; Brandt L
    Acta Haematol; 1976; 55(2):73-80. PubMed ID: 816145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythroblastic islands and extra-medullary erythropoiesis in chronic myeloid leukaemia.
    Sjögren U
    Acta Haematol; 1976; 55(5-2):272-6. PubMed ID: 821290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of bone marrow and splenic erythropoiesis in myelofibrosis.
    Ferrant A; Rodhain J; Cauwe F; Cogneau M; Beckers C; Michaux JL; Verwilghen R; Sokal G
    Scand J Haematol; 1982 Nov; 29(5):373-80. PubMed ID: 7156888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effects of an extramedullary tumor on bone marrow erythropoiesis and stroma.
    DeGowin RL; Gibson DP
    Exp Hematol; 1978 Jun; 6(6):568-75. PubMed ID: 668832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant myelosclerosis.
    Lubin J; Rozen S; Rywlin M
    Arch Intern Med; 1976 Feb; 136(2):141-5. PubMed ID: 1247344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simultaneous study of bone marrow, spleen, and liver in chronic myeloid leukemia: evidence for differences in cell composition and karyotypes.
    Baccarani M; Zaccaria A; Santucci AM; Bagnara GP; Ricci P; Gobbi M; Ruggero D; Brunelli MA; Tura S
    Ser Haematol; 1975; 8(4):81-112. PubMed ID: 1071286
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myeloid leukemia with myelofibrosis (author's transl)].
    Duhamel G; Gorin NC; Najaman A; André R
    Nouv Rev Fr Hematol; 1975; 15(1):99-105. PubMed ID: 126427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythroblastic islands and ineffective erythropoiesis in acute myeloid leukaemia.
    Sjögren U
    Acta Haematol; 1975; 54(1):11-7. PubMed ID: 808074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic myelofibrosis accompanied by peritoneal extramedullary hematopoiesis presenting as refractory ascites in a dog.
    Rautenbach Y; Goddard A; Clift SJ
    Vet Clin Pathol; 2017 Mar; 46(1):46-53. PubMed ID: 27874969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ progenitor cells in idiopathic (primary) myelofibrosis: a comparative quantification between spleen and bone marrow tissue.
    Thiele J; Kvasnicka HM; Czieslick C
    Ann Hematol; 2002 Feb; 81(2):86-9. PubMed ID: 11907788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial-to-Mesenchymal Transition in Bone Marrow and Spleen of Primary Myelofibrosis.
    Erba BG; Gruppi C; Corada M; Pisati F; Rosti V; Bartalucci N; Villeval JL; Vannucchi AM; Barosi G; Balduini A; Dejana E
    Am J Pathol; 2017 Aug; 187(8):1879-1892. PubMed ID: 28728747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agnogenic myeloid metaplasia.
    Block M
    Rev Bras Pesqui Med Biol; 1974; 7(2):185-95. PubMed ID: 4527643
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative studies of bone marrow and extramedullary haemopoietic tissue in chronic myeloid leukemia.
    Brandt L
    Ser Haematol; 1975; 8(4):75-80. PubMed ID: 1071285
    [No Abstract]   [Full Text] [Related]  

  • 15. Essential thrombocythemia terminating in myelofibrosis and myeloblastic transformation.
    Yonemitsu H; Okuda K
    Jpn J Med; 1985 Feb; 24(1):57-61. PubMed ID: 3858568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ineffective erythropoiesis in myeloid splenomegaly: the 59Fe test, bone marrow histologic and cytologic data].
    Charbord P; Caillou B; Lafleur M; Parmentier C
    Nouv Rev Fr Hematol (1978); 1978 Nov; 20(3):443-53. PubMed ID: 754175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy resolves symptoms and reverses marrow fibrosis in myelofibrosis.
    Manoharan A; Pitney WR
    Scand J Haematol; 1984 Nov; 33(5):453-9. PubMed ID: 6515328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelofibrosis.
    Kakkar R; Ahuja IS
    J Indian Med Assoc; 1970 Sep; 55(6):204-6. PubMed ID: 5501471
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphologic studies of the erythropoietic part of bone marrow in myeloid leukaemias.
    Sjögren U
    Scand J Haematol; 1979 Jan; 22(1):61-6. PubMed ID: 284582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty bone marrow with severe myeloid hypoplasia in idiopathic myelofibrosis.
    Polino G; Barosi G; Berzuini A; Castelli G; Isernia P; Palestra P; Riccardi A; Rossi F; Magrini U
    Haematologica; 1986; 71(2):117-21. PubMed ID: 3087832
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.